B Lynne Parshall

Director

B Lynne Parshall (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $414K of IONS (5,000 sh × $82.72, as filed), executed Feb 11.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.5M

shares × price, as filed

Last traded

Sep 1

Filed Sep 1

Median ADV $142.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

IONS Ionis Pharmaceuticals, Inc. IONS · 0 buys · 5 sells 5 filings CYTK

Cytokinetics, Incorporated CYTK · 0 buys · 4 sells 4 filings

Recent filings

IONSSALE Ionis Pharmaceuticals, Inc. View filing → $193K
4,600 sh × $41.87
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $275K
5,000 sh × $54.92
Exec Sep 9 2024
Filed Sep 9 2024 · 5:30 PM ET